Michael is Professor of Neurology and Genomic Medicine at Imperial College London with over 15-year’s experience with pharmaceutical and biotechnology companies spanning basic science to clinical development and drug trials. Michael graduated from Oxford (PhD in molecular genetics) and St Bartholomew’s Hospital Medical School (Medicine) and has over 20-years’ experience as Principle Investigator and as a consultant clinical neurologist. Michael has pioneered the development of applied systems biology for drug target and biomarker discovery with over 100 journal articles and book chapters including in leading scientific journals such as Nature, Nature Genetics, Nature Neuroscience and Nature Communications.